These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 16301833

  • 21. The future development of bevacizumab in colorectal cancer.
    Díaz-Rubio E, Schmoll HJ.
    Oncology; 2005; 69 Suppl 3():34-45. PubMed ID: 16301834
    [Abstract] [Full Text] [Related]

  • 22. Aflibercept. Metastatic colorectal cancer: at least as poorly tolerated as bevacizumab.
    Prescrire Int; 2014 Sep; 23(152):205. PubMed ID: 25325116
    [Abstract] [Full Text] [Related]

  • 23. Bevacizumab in the treatment of metastatic colorectal cancer.
    Caprioni F, Fornarini G.
    Future Oncol; 2007 Apr; 3(2):141-8. PubMed ID: 17381413
    [Abstract] [Full Text] [Related]

  • 24. Bevacizumab for advanced colorectal cancer.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2004 Dec; (63):1-4. PubMed ID: 15612152
    [Abstract] [Full Text] [Related]

  • 25. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.
    Chen HX, Mooney M, Boron M, Vena D, Mosby K, Grochow L, Jaffe C, Rubinstein L, Zwiebel J, Kaplan RS.
    J Clin Oncol; 2006 Jul 20; 24(21):3354-60. PubMed ID: 16849749
    [Abstract] [Full Text] [Related]

  • 26. Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer.
    Hochster HS.
    Semin Oncol; 2006 Oct 20; 33(5 Suppl 10):S8-14. PubMed ID: 17145525
    [Abstract] [Full Text] [Related]

  • 27. Experience with bevacizumab in the management of epithelial ovarian cancer.
    Burger RA.
    J Clin Oncol; 2007 Jul 10; 25(20):2902-8. PubMed ID: 17617521
    [Abstract] [Full Text] [Related]

  • 28. Fournier's gangrene as a possible side effect of bevacizumab therapy for resected colorectal cancer.
    Gamboa EO, Rehmus EH, Haller N.
    Clin Colorectal Cancer; 2010 Jan 10; 9(1):55-8. PubMed ID: 20100690
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Surgical management of bevacizumab-associated peritonitis due to perforation].
    Kube R, Meyer F, Bien N, Schmidt C, Mroczkowski P, Dalicho S, Lippert H.
    Zentralbl Chir; 2009 Sep 10; 134(5):462-7. PubMed ID: 19757347
    [Abstract] [Full Text] [Related]

  • 31. Bevacizumab in the treatment of ovarian cancer.
    Han ES, Monk BJ.
    Expert Rev Anticancer Ther; 2007 Oct 10; 7(10):1339-45. PubMed ID: 17944559
    [Abstract] [Full Text] [Related]

  • 32. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
    Abbrederis K, Kremer M, Schuhmacher C.
    Chirurg; 2008 Apr 10; 79(4):351-5. PubMed ID: 17453167
    [Abstract] [Full Text] [Related]

  • 33. [Efficacy of chemotherapy combined with bevacizumab for metastatic colorectal cancer].
    Momoi A, Motomura S, Hashimoto C, Takasaki H, Takemura S, Takagi S, Akaike M.
    Gan To Kagaku Ryoho; 2011 Jan 10; 38(1):79-83. PubMed ID: 21368462
    [Abstract] [Full Text] [Related]

  • 34. Bevacizumab, bleeding, thrombosis, and warfarin.
    Kilickap S, Abali H, Celik I.
    J Clin Oncol; 2003 Sep 15; 21(18):3542; author reply 3543. PubMed ID: 12972536
    [No Abstract] [Full Text] [Related]

  • 35. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
    Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F.
    J Clin Oncol; 2005 May 20; 23(15):3502-8. PubMed ID: 15908660
    [Abstract] [Full Text] [Related]

  • 36. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
    Prescrire Int; 2006 Jun 20; 15(83):94-7. PubMed ID: 16764097
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Evaluation of bevacizumab for advanced colorectal cancer].
    Naito M, Hoshino S, Noda N, Nakano M, Matsuo K, Yamauchi Y, Shinohara T, Tanaka S, Yamashita Y.
    Gan To Kagaku Ryoho; 2010 Jan 20; 37(1):83-8. PubMed ID: 20087037
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.